FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048276557> ?p ?o ?g. }

• W3048276557 endingPage "152" @default.
• W3048276557 startingPage "1" @default.
• W3048276557 abstract "Background In the UK, juvenile idiopathic arthritis is the most common inflammatory disorder in childhood, affecting 10 : 100,000 children and young people aged < 16 years each year, with a population prevalence of around 1 : 1000. Corticosteroids are commonly used to treat juvenile idiopathic arthritis; however, there is currently a lack of consensus as to which corticosteroid induction regimen should be used with various disease subtypes and severities of juvenile idiopathic arthritis. Objective The main study objective was to determine the feasibility of conducting a randomised controlled trial to compare the different corticosteroid induction regimens in children and young people with juvenile idiopathic arthritis. Design This was a mixed-methods study. Work packages included a literature review; qualitative interviews with children and young people with juvenile idiopathic arthritis and their families; a questionnaire survey and screening log to establish current UK practice; a consensus meeting with health-care professionals, children and young people with juvenile idiopathic arthritis, and their families to establish the primary outcome; a feasibility study to pilot data capture and to collect data for future sample size calculations; and a final consensus meeting to establish the final protocol. Setting The setting was rheumatology clinics across the UK. Participants Children, young people and their families who attended clinics and health-care professionals took part in this mixed-methods study. Interventions This study observed methods of prescribing corticosteroids across the UK. Main outcome measures The main study outcomes were the acceptability of a future trial for children, young people, their families and health-care professionals, and the feasibility of delivering such a trial. Results Qualitative interviews identified differences in the views of children, young people and their families on a randomised controlled trial and potential barriers to recruitment. A total of 297 participants were screened from 13 centres in just less than 6 months. In practice, all routes of corticosteroid administration were used, and in all subtypes of juvenile idiopathic arthritis. Intra-articular corticosteroid injection was the most common treatment. The questionnaire surveys showed the varying clinical practice across the UK, but established intra-articular corticosteroids as the treatment control for a future trial. The primary outcome of choice for children, young people, their families and health-care professionals was the Juvenile Arthritis Disease Activity Score, 71-joint count. However, results from the feasibility study showed that, owing to missing blood test data, the clinical Juvenile Arthritis Disease Activity Score should be used. The Juvenile Arthritis Disease Activity Score, 71-joint count, and the clinical Juvenile Arthritis Disease Activity Score are composite disease activity scoring systems for juvenile arthritis. Two final trial protocols were established for a future randomised controlled trial. Limitations Fewer clinics were included in this feasibility study than originally planned, limiting the ability to draw strong conclusions about these units to take part in future research. Conclusions A definitive randomised controlled trial is likely to be feasible based on the findings from this study; however, important recommendations should be taken into account when planning such a trial. Future work This mixed-methods study has laid down the foundations to develop the evidence base in this area and conducting a randomised control trial to compare different corticosteroid induction regimens in children and young people with juvenile idiopathic arthritis is likely to be feasible. Study registration Current Controlled Trials ISRCTN16649996. Funding This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment ; Vol. 24, No. 36. See the NIHR Journals Library website for further project information." @default.
• W3048276557 created "2020-08-13" @default.
• W3048276557 creator A5005129884 @default.
• W3048276557 creator A5013982414 @default.
• W3048276557 creator A5014525308 @default.
• W3048276557 creator A5015700716 @default.
• W3048276557 creator A5019382271 @default.
• W3048276557 creator A5024881582 @default.
• W3048276557 creator A5041204910 @default.
• W3048276557 creator A5048248458 @default.
• W3048276557 creator A5048797883 @default.
• W3048276557 creator A5053827033 @default.
• W3048276557 creator A5054508057 @default.
• W3048276557 creator A5062151567 @default.
• W3048276557 creator A5068458849 @default.
• W3048276557 creator A5071704248 @default.
• W3048276557 creator A5072801492 @default.
• W3048276557 creator A5090311068 @default.
• W3048276557 date "2020-07-01" @default.
• W3048276557 modified "2023-10-10" @default.
• W3048276557 title "Different corticosteroid induction regimens in children and young people with juvenile idiopathic arthritis: the SIRJIA mixed-methods feasibility study" @default.
• W3048276557 cites W1506931913 @default.
• W3048276557 cites W1507110078 @default.
• W3048276557 cites W1587443401 @default.
• W3048276557 cites W1808221356 @default.
• W3048276557 cites W181033957 @default.
• W3048276557 cites W1953534612 @default.
• W3048276557 cites W1968091931 @default.
• W3048276557 cites W1968230810 @default.
• W3048276557 cites W1976770755 @default.
• W3048276557 cites W1990191945 @default.
• W3048276557 cites W1995070454 @default.
• W3048276557 cites W1997210060 @default.
• W3048276557 cites W2007468708 @default.
• W3048276557 cites W2007664096 @default.
• W3048276557 cites W2010149513 @default.
• W3048276557 cites W2012855434 @default.
• W3048276557 cites W2013874459 @default.
• W3048276557 cites W2017532745 @default.
• W3048276557 cites W2020395064 @default.
• W3048276557 cites W2024714476 @default.
• W3048276557 cites W2039634120 @default.
• W3048276557 cites W2039662308 @default.
• W3048276557 cites W2042832733 @default.
• W3048276557 cites W2047456984 @default.
• W3048276557 cites W2050421993 @default.
• W3048276557 cites W2054276574 @default.
• W3048276557 cites W2055319037 @default.
• W3048276557 cites W2059707463 @default.
• W3048276557 cites W2063022713 @default.
• W3048276557 cites W2069217310 @default.
• W3048276557 cites W2072481460 @default.
• W3048276557 cites W2073700972 @default.
• W3048276557 cites W2074499461 @default.
• W3048276557 cites W2079894203 @default.
• W3048276557 cites W2083588497 @default.
• W3048276557 cites W2087730640 @default.
• W3048276557 cites W2090905345 @default.
• W3048276557 cites W2094834582 @default.
• W3048276557 cites W2098015409 @default.
• W3048276557 cites W2102725242 @default.
• W3048276557 cites W2103029011 @default.
• W3048276557 cites W2104881646 @default.
• W3048276557 cites W2107411427 @default.
• W3048276557 cites W2108546319 @default.
• W3048276557 cites W2109575571 @default.
• W3048276557 cites W2111525602 @default.
• W3048276557 cites W2113409788 @default.
• W3048276557 cites W2114990760 @default.
• W3048276557 cites W2117209504 @default.
• W3048276557 cites W2117798438 @default.
• W3048276557 cites W2118749389 @default.
• W3048276557 cites W2119294527 @default.
• W3048276557 cites W2119767902 @default.
• W3048276557 cites W2121699204 @default.
• W3048276557 cites W2132396893 @default.
• W3048276557 cites W2133124363 @default.
• W3048276557 cites W2134171514 @default.
• W3048276557 cites W2135974703 @default.
• W3048276557 cites W2136668724 @default.
• W3048276557 cites W2138664283 @default.
• W3048276557 cites W2139339819 @default.
• W3048276557 cites W2141650877 @default.
• W3048276557 cites W2141690434 @default.
• W3048276557 cites W2144177631 @default.
• W3048276557 cites W2148530248 @default.
• W3048276557 cites W2150615436 @default.
• W3048276557 cites W2153402712 @default.
• W3048276557 cites W2154393487 @default.
• W3048276557 cites W2155109530 @default.
• W3048276557 cites W2156865198 @default.
• W3048276557 cites W2161305892 @default.
• W3048276557 cites W2162351377 @default.
• W3048276557 cites W2162697526 @default.
• W3048276557 cites W2167875511 @default.
• W3048276557 cites W2168610960 @default.
• W3048276557 cites W2168790852 @default.
• W3048276557 cites W2169460191 @default.

• next